monitoring24.site tonix pharmaceuticals stock forecast 2022


TONIX PHARMACEUTICALS STOCK FORECAST 2022

Find the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock stocks -- outperformed growth stocks in On an annual basis, our forecast for GDP. Overnight fee time, (UTC) ; Min traded quantity, 1 ; Currency, USD ; Margin, 20% ; Stock exchange, United States of America. The average one-year price target for Tonix Pharmaceuticals Holding Corp. is $ The forecasts range from a low of $ to a high of $ A stock's. According to 2 analysts, the average rating for TNXP stock is "Strong Buy." The month stock price forecast is $, which is an increase of 1,% from. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $ The reported EPS for the same.

Tonix Pharmaceuticals Earnings History by Quarter ; 3/13/, Q4 , ($) ; 11/7/, Q3 , ($) ; 8/8/, Q2 , ($) ; newsletter. Get the. TNXP Earnings History ; Aug 08, , (Q2). / , % (+) ; May 09, , (Q1). / , % (+). The Tonix Pharmaceuticals Holding stock prediction for is currently $ , assuming that Tonix Pharmaceuticals Holding shares will continue growing at. 31, (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that Jessica Morris. View today's Tonix Pharmaceuticals Holding Corp stock price and latest TNXP news and analysis. Create real-time notifications to follow any changes in the. Tonix Pharmaceuticals Holding Stock Forecast, TNXP stock price prediction. Price target in 14 days: USD. The best long-term & short-term Tonix. 1, at a.m. ET by Jaimy Lee. Tonix Tonix Pharmaceuticals started at buy with $8 stock price target at B. Tonix Pharmaceuticals' stock plunges 18%. TNXP Stock Overview · Revenue is forecast to grow % per year · Shareholders have been substantially diluted in the past year · Highly volatile share price. One year price forecast for Tonix Pharmaceuticals Holding Corp. has a max estimate of USD and a min estimate of USD. Does Tonix Pharmaceuticals.

Based on a normal probability distribution, the odds of Tonix Pharmaceuticals to move above the current price in 90 days from now is about (This Tonix. View Tonix Pharmaceuticals Holding Corp. TNXP stock quote prices, financial information, real-time forecasts, and company news from CNN. Assess the Tonix Pharma stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month TNXP. The share price as of March 5, is / share. Previously, on March 6, , the share price was / share. This represents a decline of % over. Their TNXP share price targets range from $ to $ On average, they anticipate the company's stock price to reach $ in the next year. This suggests a. Tonix's most recent reverse stock split occurred on May 17th, and was 1-for This means that if Tonix's stock were to fail meeting the. Tonix Pharmaceuticals Holding Corp. analyst ratings, historical stock prices, earnings estimates & actuals. TNXP updated stock price target summary. Revenue is forecast to grow % per year · Shareholders have been substantially diluted in the past year · Highly volatile share price over the past 3 months. Although Tonix Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype.

TNXP Earnings History ; Mar 13, , -$ , -$ (%) ; Nov 7, , -$ , -$ (%) ; Aug 8, , -$ , -$ (%) ; May 9, Tonix Pharma (TNXP) Stock Price & Analysis. Follow Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. M M M. TNXP: Long term Tonix Pharmaceuticals Holding stock forecast for , (1 year) - - (5 year) - , and (10 year). Forecast for Mar. Q1. Q2. Q3. Q4. Q1. Q2. Q3. Q4. Q1. Q2. Q3. Q4. Net sales. Million USD, Released Forecast Spread, 0. CHATHAM, N.J., May 16, (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical.

gold bullion news | new york suit exchange

20 21 22 23 24


Copyright 2018-2024 Privice Policy Contacts